Literature DB >> 15516698

Treating diabetic nephropathy--are there only economic issues?

William E Mitch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516698     DOI: 10.1056/NEJMp048254

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.

Authors:  Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong-Van den Berg; Paul E de Jong; Dick de Zeeuw; Lieven J P Annemans; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Diabetic nephropathy: lessons from the mouse.

Authors:  Himanshu Vashistha; Leonard Meggs
Journal:  Ochsner J       Date:  2013

3.  Pursuing Diabetic Nephropathy through Aqueous Humor Proteomics Analysis.

Authors:  Huan Chen; Tan Wang; Erqian Wang; Ningning Li; Hanyi Min
Journal:  Oxid Med Cell Longev       Date:  2022-09-29       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.